Sri Venkateswara Galaxy Medical Distributors Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 19-06-2024
- Paid Up Capital ₹ 1.50 M
as on 19-06-2024
- Company Age 3 Year, 16 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.50 Cr
as on 19-06-2024
About Sri Venkateswara Galaxy Medical Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹25.50 Cr.
Venkatarathnam Potineni, Jamuna Yelamanchi, and Narasaiah Arigela serve as directors at the Company.
- CIN/LLPIN
U51909AP2021PTC120262
- Company No.
120262
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Dec 2021
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Chittoor, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sri Venkateswara Galaxy Medical Distributors?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatarathnam Potineni  | Director | 07-Dec-2021 | Current |
| Jamuna Yelamanchi | Director | 07-Dec-2021 | Current |
| Narasaiah Arigela | Additional Director | 02-Feb-2024 | Current |
Financial Performance of Sri Venkateswara Galaxy Medical Distributors.
Sri Venkateswara Galaxy Medical Distributors Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sri Venkateswara Galaxy Medical Distributors?
Unlock access to Sri Venkateswara Galaxy Medical Distributors's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
New Viswabharathy Drug Lines Private LimitedActive 2 years 7 monthsNarasaiah Arigela is a mutual person
- Prime Time Logistics Technologies Private LimitedActive 33 years 8 months
Narasaiah Arigela is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Jul 2022 | ₹25.50 Cr | Open |
How Many Employees Work at Sri Venkateswara Galaxy Medical Distributors?
Unlock and access historical data on people associated with Sri Venkateswara Galaxy Medical Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Venkateswara Galaxy Medical Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Venkateswara Galaxy Medical Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
